$0.074
-0.027 (-37.11%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BTAI por análisis de gráficos similares
Alphio's BTAI stock price prediction model matches the current BioXcel Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.07 (-0.11%). The 1-week path is $0.07 (+0.62%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de BioXcel Therapeutics Inc?
BioXcel Therapeutics Inc is not a good buy right now due to its significant financial distress and recent bankruptcy filing. The current price is $0.0739, which reflects a staggering 95.65% decline year-to-date. Additionally, the company has reported a gross margin of only 87.91% in the most recent quarter, indicating severe operational challenges. The primary risk is its recent bankruptcy filing, which raises concerns about the company's ability to continue operations and meet obligations.
BTAI cerró en $0.07 el Friday, tras bajar -37.11%
BioXcel Therapeutics Inc (BTAI) last closed at $0.0739, losing -37.11%. These facts feed the 1-day and 1-week BTAI price prediction above.
Consenso de analistas
BioXcel Therapeutics Inc (BTAI): 4 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de BioXcel Therapeutics Inc (BTAI) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BTAI, ordenadas por similitud.
Análisis de estacionalidad de BTAI
Historically the probability of a positive November return for BTAI is 0.00%. January offers the highest probability of a positive month at 39.34%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BTAI
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.92 | $0.94 | $0.95 | +1166.93% |
| Dec 2026 | $0.70 | $0.86 | $0.94 | +1064.31% |
En 2026, se proyecta que BioXcel Therapeutics Inc (BTAI) oscile entre $0.70 y $0.95.
Previsión mensual de BioXcel Therapeutics Inc para 2026
En Nov de 2026, se proyecta que BioXcel Therapeutics Inc promedie $0.94, con un mínimo de $0.92 y un máximo de $0.95.
En Dec de 2026, se proyecta que BioXcel Therapeutics Inc promedie $0.86, con un mínimo de $0.70 y un máximo de $0.94.
Artículos relacionados
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
- Bitcoin Bear Market 2026: Why BTC Fell Below $70K and How Investors Can Manage Crypto RiskBitcoin is about 45% below its $126K peak as Fed hikes, 5% yields and ETF outflows bite. See how the 2026 bear market compares and how to manage crypto risk.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.